Curative Biotechnology, Inc.

Curative Biotechnology, Inc.verified

CUBT

Price:

$1.4

Market Cap:

$9.55M

Curative Biotechnology, Inc. is an emerging biomedical firm primarily focused on developing pharmaceutical products. Its research and development efforts are concentrated on a diverse pipeline targeting critical therapeutic areas, including infectious diseases, cancer, and vision-impairing degenerative eye conditions. Among its key pipeline assets is IMT504, an innovative immunotherapy designed for rabies treatment and as a vaccine enhancer. Another prominent candidate is CUBT906, a fully humanized CD56 monoclonal antibody that delivers a pyrrolobenzodiazepine dimer directly to tumor cells, aiming to eradicate them by halting their growth and spread. Additionally, the company is advancing a ...[Read more]

Industry

Biotechnology

IPO Date

1998-03-30

Stock Exchange

OTC

Ticker

CUBT

The PE Ratio as of June 2026 (TTM) for Curative Biotechnology, Inc. (CUBT) is -1.43

According to Curative Biotechnology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.43. This represents a change of -70.51% compared to the average of -4.85 of the last 4 quarters.

Curative Biotechnology, Inc. (CUBT) Historical PE Ratio (quarterly & annually)

How has CUBT PE Ratio performed in the past?

The mean historical PE Ratio of Curative Biotechnology, Inc. over the last ten years is -38.43. The current -1.43 PE Ratio has changed 272.07% with respect to the historical average. Over the past ten years (40 quarters), CUBT's PE Ratio was at its highest in in the September 2013 quarter at 46.22. The PE Ratio was at its lowest in in the June 2020 quarter at -469.53.

Quarterly (TTM)
Annual

Average

-38.43

Median

-2.69

Minimum

-364.22

Maximum

2.19

Curative Biotechnology, Inc. (CUBT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Curative Biotechnology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 11.07%

Maximum Annual PE Ratio = 2.19

Minimum Annual Increase = -302.76%

Minimum Annual PE Ratio = -364.22

Quarterly (TTM)
Annual
YearPE RatioChange
2025-364.2211.07%
2024-3.26-8.69%
2023-3.5770.63%
2022-2.09-58.70%
2021-5.07138.95%
2020-2.12-196.90%
20192.19-302.76%
2018-1.08-23.17%
2017-1.40-62.15%
2016-3.71-246.23%

Curative Biotechnology, Inc. (CUBT) Average PE Ratio

How has CUBT PE Ratio performed in the past?

The current PE Ratio of Curative Biotechnology, Inc. (CUBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-123.68

5-year avg

-75.64

10-year avg

-38.43

Curative Biotechnology, Inc. (CUBT) PE Ratio vs. Peers

How is CUBT’s PE Ratio compared to its peers?

Curative Biotechnology, Inc.’s PE Ratio is less than Quantum Genomics S.A. (-0.57), less than ProText Mobility, Inc. (99.93), less than Chimeric Therapeutics Limited (-0.15), greater than BetterLife Pharma Inc. (-7.11), less than Theralink Technologies, Inc. (-0.00), greater than Mosaic ImmunoEngineering Inc. (-7.15), less than BioVaxys Technology Corp. (-0.62), greater than Glow Lifetech Corp. (-15.63), less than Futura Medical plc (-0.37), greater than NanoSphere Health Sciences Inc. (-1.77),

Build a custom stock screener for Curative Biotechnology, Inc. (CUBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Curative Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Curative Biotechnology, Inc. (CUBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Curative Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Curative Biotechnology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Curative Biotechnology, Inc. (CUBT)?

What is the highest PE Ratio for Curative Biotechnology, Inc. (CUBT)?

What is the 3-year average PE Ratio for Curative Biotechnology, Inc. (CUBT)?

What is the 5-year average PE Ratio for Curative Biotechnology, Inc. (CUBT)?

How does the current PE Ratio for Curative Biotechnology, Inc. (CUBT) compare to its historical average?